首页> 外文期刊>Current pharmaceutical design >Assessing schizophrenia-relevant cognitive and social deficits in mice: a selection of mouse behavioral tasks and potential therapeutic compounds.
【24h】

Assessing schizophrenia-relevant cognitive and social deficits in mice: a selection of mouse behavioral tasks and potential therapeutic compounds.

机译:评估小鼠中与精神分裂症相关的认知和社交缺陷:小鼠行为任务和潜在治疗化合物的选择。

获取原文
获取原文并翻译 | 示例
           

摘要

Schizophrenia and other psychiatric disorders are generally diagnosed based on a collection of symptoms defined by a combination of an individual's feelings, perceptions, and behaviors. Many of these disorders are characterized by specific cognitive and social deficits. Although it is nearly impossible to recapitulate the full phenotypic spectrum of schizophrenia in mice, mouse models play an indispensable role in understanding the pathogenesis of this disorder and the development of new therapeutics. Genetic mouse models of schizophrenia and mouse behavioral tests provide a feasible approach for elucidating causal relationships between susceptibility gene(s) and schizophrenia-related symptoms. There has been a proliferation of studies characterizing basic behavioral phenotypes in mice. Since there is no way to completely model human psychiatric symptoms in mice, the major role of behavioral tests is to provide insights into underlying affected circuitry and pathophysiology. Given that the recovery of cognitive and social abilities significantly benefits functional outcomes, there has been an increasing interest in characterizing cognitive and social functions in mutant mice; however, these functions are not easy to measure. In this review, a selection of conventional behavioral tasks was briefly described and three specific behavioral tasks aimed at characterizing social communication, attentional function, and choice behavior in mice were highlighted. The choice of specific behavioral tasks during experimental planning should take into consideration a variety of factors, including their validity, reliability, sensitivity, utility, and specificity. Based upon the hypothetical hypofunction of N-methyl-D-aspartate receptor (NMDAR)-mediated signaling pathways in the involvement of cognitive and social impairments in schizophrenia, three NMDAR-related compounds/drugs, D-serine, sarcosine, and D-cycloserine, are discussed as an example.
机译:精神分裂症和其他精神疾病通常是根据一系列症状来诊断的,这些症状是由个人的感觉,感知和行为共同决定的。这些疾病中许多以特定的认知和社会缺陷为特征。尽管几乎不可能在小鼠中概括精神分裂症的全部表型谱,但小鼠模型在了解这种疾病的发病机理和开发新疗法方面起着不可或缺的作用。精神分裂症的遗传小鼠模型和小鼠行为测试为阐明易感基因与精神分裂症相关症状之间的因果关系提供了一种可行的方法。表征小鼠基本行为表型的研究激增。由于无法完全模拟小鼠的人类精神症状,因此行为测试的主要作用是提供对潜在的受影响电路和病理生理学的见识。鉴于认知能力和社交能力的恢复显着有益于功能预后,对表征突变小鼠的认知功能和社交功能的兴趣日益浓厚。但是,这些功能不容易测量。在这篇综述中,简要描述了常规行为任务的选择,并着重介绍了旨在表征小鼠社交,注意功能和选择行为的三个具体行为任务。在实验计划中选择特定的行为任务时,应考虑多种因素,包括其有效性,可靠性,敏感性,效用和特异性。基于N-甲基-D-天冬氨酸受体(NMDAR)介导的信号通路在精神分裂症的认知和社会障碍中的假设功能低下,三种与NMDAR相关的化合物/药物,D-丝氨酸,肌氨酸和D-环丝氨酸作为示例进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号